3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Recurrence
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Lenalidomide
2
sargramostim
1
plerixafor
1
pegylated granulocyte colony-stimulating factor
1
montanide ISA 51
1
incomplete Freund's adjuvant
1
fludarabine phosphate
1
fludarabine
1
ferric pyrophosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
auricularum
1
Whole-Body Irradiation
1
Stem Cell Transplantation
1
Specimen Handling
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Hyaluronoglucosaminidase
1
Fluorodeoxyglucose F18
1
Dexamethasone
1
Cyclosporine
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Calcium Dobesilate
1
Budesonide
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Plasma Cell
×
Antilymphocyte Serum
×
30 days
×
Clear all
No trials found.